Single-Use Bioprocessing Probes & Sensors Market Size, Share & Trends Analysis Report By Sensor Type (pH Sensor, Oxygen Sensor, Pressure Sensors, Temperature Sensors, Conductivity Sensors, Flow Meters & Sensors, Others), By Workflow (Upstream, Downstream), By End-use (Biopharmaceutical Manufacturer (CMOs & CROs, In-house Manufacturer), Labs & Academic/ Clinical Research Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Single-Use Bioprocessing Probes & Sensors Market Size

The global single-use bioprocessing probes & sensors market size was valued at USD 3.51 billion in 2025 and is projected to grow from USD 3.95 billion in 2026 to USD 10.24 billion by 2034, registering a CAGR of 12.63% during the forecast period from 2026 to 2034. North America dominated the single-use bioprocessing probes & sensors market with a market share of 38.6% in 2025.

The adoption of single-use bioprocessing equipment is gradually gaining momentum in biopharmaceutical manufacturing. The growing demand for biopharmaceuticals is consequently driving the need for single-use systems. With the increase in the adoption of single-use systems, biopharmaceutical manufacturers are demanding robust and innovative single-use probes and sensors that would help fulfill the requirements of effective monitoring of various parameters, such as dissolved oxygen, pH, and others, throughout the bioprocessing process.

Segmental Analysis

By Sensor Type

The global single-use bioprocessing probes & sensors market is segmented into pH sensors, pressure sensors, oxygen sensors, temperature sensors, conductivity sensors, flow meters & sensors, among others. The pH sensor segment dominated the market share and is estimated to register a CAGR of 15.3% during the forecast period. Due to expanding biopharmaceutical manufacturing capabilities, single-use bioreactors have been in high demand in recent years. Owing to this, the need for single-use pH sensors is also anticipated to increase. Optical sensors are considered the most commonly used/standard devices for pH measuring. This can be attributed to features of these sensors, such as contactless measurement or minimal invasion, pre-calibration, easy integration with SUBs, and high accuracy. Furthermore, Sartorius Stedim Biotech and Metroglas have developed a single-use gamma-stable electrochemical pH probe. However, using gamma stable, low drift, and easy-to-integrate single-use pH sensors is limited in the biopharmaceutical industry.

Request Customizationto receive a tailored report.

By Workflow

The global single-use bioprocessing probes & sensors market is segmented into upstream and downstream. The upstream segment accounted for the largest market share and is estimated to register a CAGR of 14.4% during the forecast period. Various single-use systems are available for upstream bioprocessing applications. With the development of several disposable products for upstream processing, the demand for single-use probes and sensors is also anticipated to increase in the coming years. Probes and sensors are crucial in monitoring all Critical Process Parameters (CPPs) during cell culture in a bioreactor. The sensors used in upstream bioprocessing are either online or offline. Online sensors are further divided into in-line and at-line sensors. These sensors provide advantages such as eliminating the risk of cross-contamination and accurate monitoring of parameters, leading to enhanced productivity.

By End-Use

The global single-use bioprocessing probes & sensors market is segmented into biopharmaceutical manufacturers (CMOS & CROs, In-house manufacturers), labs & academic/ clinical research institutes. The biopharmaceutical manufacturer segment accounted for the largest market share and is estimated to grow at a CAGR of 14.4% during the forecast period. The growth of continuous bioprocessing coupled with the advantages of single-use technology has led to increasing demand for single-use sensors in the market. Biopharmaceutical manufacturing is shifting to producing non-blockbuster drugs, and the adoption of single-use technologies is also growing. In addition, many biopharmaceutical companies have redesigned or expanded their manufacturing facilities to incorporate single-use technology in their manufacturing workflow. The confluence of the abovementioned factors is anticipated to drive the segment in the coming years. Moreover, commercial advantages of single-use sensors, such as cost-effectiveness, reduced labor charges, and others, are also expected to increase the application of these products in the biopharmaceutical industry in the near future.

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America: Dominant Region

North America dominated the single-use probes and sensors market and is estimated to register a CAGR of 13.3% during the forecast period. This is attributed to the increasing adoption of new technologies, such as Single-use Technology (SUT), coupled with significant biopharmaceutical and biotechnology industries. In addition, the expanding applications of disposables at biomanufacturing plants by various companies, including in-house and CMOS, are contributing significantly to the revenue growth of this region. In January 2020, 3i Group announced the establishment of a single-use bioprocessing facility through the acquisition of Silicone Altimex, Cellon, and TBL Performance Plastics to serve the North American market. In January 2018, Abzena collaborated with Sartorius Stedim Biotech to install single-use manufacturing systems at San Diego and Bristol facilities. Increasing investment in single-use technology by companies is expected to propel the market in the region further. For instance, in June 2019, Thermo Fisher Scientific invested USD 50 million in bioproduction capabilities to further scale up its single-use manufacturing systems in Logan, U.S. Chicago-headquartered GE Healthcare has made numerous investments in single-use technologies. In 2016, the company expanded its manufacturing capacity in Westborough, MA, with an acquisition of USD 7 million. Such initiatives are expected to positively impact North America's revenue generation, leading to its leading market share.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific: Growing Region

Asia Pacific is the second largest region. It is estimated to reach an expected USD 2700 million by 2030 at a CAGR of 16.2%. Asia Pacific is anticipated to show significant growth in the single-use probes and sensors market. This can be attributed to the broad reach of biotechnology and increasing technological innovations in the region. In addition, expanding application of single-use technologies in biopharmaceuticals, growing adoption of disposables in biomanufacturing, and cost-effectiveness of disposable products are anticipated to impact the market's revenue generation in the region positively. Furthermore, the region's increasing biopharmaceutical and biotechnology sector is anticipated to accelerate the adoption of single-use technologies, leading to increasing demand for single-use probes and sensors. Moreover, in October 2019, the Australian Federal Government invested USD 35 million in the country's biomanufacturing sector to develop biological systems to produce commercial products. Such government initiatives are expected to boost the adoption of single-use sensors in biomanufacturing.

Europe is the third largest region. Europe was ranked second, after North America, in terms of revenue generation in 2019. The increasing adoption of disposables in the biopharmaceutical industry, technological developments in bioprocessing systems, and high healthcare spending are expected to contribute to market growth in Europe. The expansion of biopharmaceutical businesses by global companies and the upgrading of manufacturing facilities by CDMOs are anticipated to drive the market further. For instance, in November 2019, AGC, Inc. expanded its biopharmaceutical production by installing a purification line in the Copenhagen facility. In March 2020, WuXi Biologics completed the construction of a large-scale commercial manufacturing facility in Ireland. This facility is equipped with single-use bioreactors. In September 2017, Swiss CDMO Celonic AG implemented MilliporeSigma's Mobius single-use bioreactors. Thus, the increasing implementation of single-use technologies is expected to propel the adoption & demand for single-use probes and sensors in the region. The key companies operating in the region are Sartorius Stedim Biotech; Equflow; Vekamaf Services B.V.; PreSens Precision Sensing GmbH; and Optek-Danulat, Inc., which are contributing significantly to the market's revenue generation in the region.

List of Key and Emerging Players in Single-Use Bioprocessing Probes & Sensors Market